193738-16-8

Basic information

• Product Name: Acetic acid, (2-acetyl-3-hydroxyphenoxy)-, methyl ester
• CAS NO: 193738-16-8
• Molecular Formula: C11H12O5
• Molecular Weight: 224.213
• Mol File: 193738-16-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Acetic acid, (2-acetyl-3-hydroxyphenoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, (2-acetyl-3-hydroxyphenoxy)-, methyl ester(193738-16-8)
• EPA Substance Registry System: Acetic acid, (2-acetyl-3-hydroxyphenoxy)-, methyl ester(193738-16-8)

Safety Data

• Hazardous Substances Data: 193738-16-8(Hazardous Substances Data)

Upstream product

• 699-83-2 2,6-dihydroxylacetophenone 
• 96-34-4 methyl chloroacetate 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 770745-68-1 4-(2-carboxyethyl)-2'-(carboxymethoxy)-6'-hydroxydihydrochalcone 
• 193738-54-4 3-Methyl-4-(4-trifluoromethyl-benzyloxy)-benzofuran-2-carboxylic acid methyl ester 
• 193738-55-5 3-Methyl-4-(4-nitro-benzyloxy)-benzofuran-2-carboxylic acid methyl ester 
• 193738-58-8 4-(2-Methoxy-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-59-9 4-(3,4-Dimethoxy-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-60-2 4-(3,5-Dimethoxy-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-51-1 4-(4-Carboxy-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-57-7 4-(3-Methoxy-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-49-7 4-(3-Chloro-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-50-0 4-(3,4-Dichloro-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 
• 193738-56-6 4-(4-methoxybenzyloxy)-3-methylbenzofuran-2-carboxylic acid, methyl ester 
• 193738-52-2 4-(4-Cyano-benzyloxy)-3-methyl-benzofuran-2-carboxylic acid methyl ester 

Relevant articles and documents

NOVEL COMPOUNDS AND THEIR USE

The present invention provides compounds of the general formula (I) or a pharmaceutically acceptable prodrugs, salts and/or solvates thereof, wherein LHS is selected from the group consisting of LHSa and LHSb And wherein, the asterisk (*) marks the point of attachment; These compounds exhibit antibacterial activity against Gram-negative and Gram-positive bacteria, especially S. aureus, E. coli, K. pneumoniae and A. baumannii. Pharmaceutical compositions containing these compounds, therapeutic uses thereof and methods for manufacturing the same are also provided.

FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF

The present invention provides fused heterocyclic derivatives represented by the general formula: wherein R1 represents H, halogen, OH, etc.; R2 represents H, halogen or an alkyl group; R3 and R4 represent H, OH, halogen, etc.; Q represents alkylene, etc.; ring A represents aryl or heteroaryl; and G represents or ???or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.